DrugPatentWatch Database Preview
Eculizumab - Biologic Drug Details
Summary for eculizumab
| Tradenames: | 1 |
| Patents: | 72 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for eculizumab |
Pharmacology for eculizumab
| Mechanism of Action | Complement Inhibitors |
US Patents for eculizumab
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alexion Pharm | SOLIRIS | eculizumab | INJECTABLE; IV (INFUSION) | 125166 | 001 | 2007-03-16 | Start Trial | CureVac AG (Tubingen, DE) | 2032-02-15 | RX | Orphan | search |
| Alexion Pharm | SOLIRIS | eculizumab | INJECTABLE; IV (INFUSION) | 125166 | 001 | 2007-03-16 | Start Trial | Genelux Corporation (San Diego, CA) | 2034-01-02 | RX | Orphan | search |
| Alexion Pharm | SOLIRIS | eculizumab | INJECTABLE; IV (INFUSION) | 125166 | 001 | 2007-03-16 | Start Trial | Alexion Pharmaceuticals, Inc. (Boston, MA) | 2029-11-05 | RX | Orphan | search |
| Alexion Pharm | SOLIRIS | eculizumab | INJECTABLE; IV (INFUSION) | 125166 | 001 | 2007-03-16 | Start Trial | CytomX Therapeutics, Inc. (South San Francisco, CA) | 2033-01-04 | RX | Orphan | search |
| Alexion Pharm | SOLIRIS | eculizumab | INJECTABLE; IV (INFUSION) | 125166 | 001 | 2007-03-16 | Start Trial | SHIRE VIROPHARMA INCORPORATED (Lexington, MA) | 2039-05-17 | RX | Orphan | search |
| Alexion Pharm | SOLIRIS | eculizumab | INJECTABLE; IV (INFUSION) | 125166 | 001 | 2007-03-16 | Start Trial | Glycotope GmbH (Berlin, DE) | 2026-09-10 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for eculizumab
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Poland | 2049501 | Start Trial |
| European Patent Office | 2694108 | Start Trial |
| Australia | 2014352846 | Start Trial |
| Hungary | E028834 | Start Trial |
| Japan | 2006020633 | Start Trial |
| Norway | 20090580 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for eculizumab
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C0016 | France | Start Trial | PRODUCT NAME: ECULIZUMAB; REGISTRATION NO/DATE: EU/1/07/393/001 20070620 |
| 0758904/01 | Switzerland | Start Trial | FORMER REPRESENTATIVE: VOSSIUS AND PARTNER, CH |
| C/GB10/015 | United Kingdom | Start Trial | PRODUCT NAME: ECULIZUMAB; REGISTERED: UK EU/1/07/393/001 20070620 |
| C002/2010 | Ireland | Start Trial | SPC002/2010: 20100902, EXPIRES: 20200430 |
| 00433 | Netherlands | Start Trial | PRODUCT NAME: ECULIZUMAB; REGISTRATION NO/DATE: EU/1/07/393/001 20070620 |
| 12/2010 | Austria | Start Trial | PRODUCT NAME: ECULIZUMAB |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
